Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 459

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Neonatal Infectious Diseases

Open access
Camacho-Gonzalez, Andres, Spearman, Paul W., Stoll, Barbara J.·2013·Pediatric Clinics of North America
DOI 10.1016/j.pcl.2012.12.003
Open this paper in CoChat — free account

Abstract

Synopsis Neonatal sepsis remains a feared cause of morbidity and mortality in the neonatal period. Maternal, neonatal and environmental factors are associated with risk of infection, and a combination of prevention strategies, judicious neonatal evaluation and early initiation of therapy are required to prevent adverse outcomes. The following chapter reviews recent trends in epidemiology, and provides an update on risk factors, diagnostic methods and management of neonatal sepsis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.pcl.2012.12.003

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 134

  1. Verani, 2010, Prevention of perinatal group B streptococcal disease—revised guidelines from CDC, 2010, MMWR Recomm Rep, 59, 1
  2. Stoll, 2002, Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants, N Engl J Med, 347, 240, 10.1056/NEJMoa012657 · DOI · Paper page
  3. Stoll, 2011, Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues, Pediatrics, 127, 817, 10.1542/peds.2010-2217 · DOI · Paper page
  4. Weston, 2011, The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008, Pediatr Infect Dis J, 30, 937, 10.1097/INF.0b013e318223bad2 · DOI
  5. Bizzarro, 2005, Seventy-five years of neonatal sepsis at Yale: 1928-2003, Pediatrics, 116, 595, 10.1542/peds.2005-0552 · DOI · Paper page
  6. Vergnano, 2011, Neonatal infections in England: the NeonIN surveillance network, Arch Dis Child Fetal Neonatal Ed, 96, F9, 10.1136/adc.2009.178798 · DOI · Paper page
  7. Stoll, 2002, Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network, Pediatrics, 110, 285, 10.1542/peds.110.2.285 · DOI · Paper page
  8. Stoll, 2010, Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network, Pediatrics, 126, 443, 10.1542/peds.2009-2959 · DOI · Paper page
  9. Baker, 2011, Policy statement—Recommendations for the prevention of perinatal group B streptococcal (GBS) disease, Pediatrics, 128, 611, 10.1542/peds.2011-1466 · DOI
  10. Kumar, 2012, Recognition of bacterial infection by innate immune sensors, Crit Rev Microbiol, 10.3109/1040841X.2012.706249 · DOI · Paper page
  11. Kollmann, 2009, Neonatal innate TLR-mediated responses are distinct from those of adults, J Immunol, 183, 7150, 10.4049/jimmunol.0901481 · DOI · Paper page
  12. Belderbos, 2012, Neonatal plasma polarizes TLR4-mediated cytokine responses towards low IL-12p70 and high IL-10 production via distinct factors, PLoS One, 7, e33419, 10.1371/journal.pone.0033419 · DOI
  13. Carr, 2000, Neutrophil production and function in newborn infants, Br J Haematol, 110, 18, 10.1046/j.1365-2141.2000.01992.x · DOI · Paper page
  14. Levy, 2007, Innate immunity of the newborn: basic mechanisms and clinical correlates, Nat Rev Immunol, 7, 379, 10.1038/nri2075 · DOI · Paper page
  15. Guilmot, 2011, Natural killer cell responses to infections in early life, J Innate Immun, 3, 280
  16. Schelonka, 2011, T cell cytokines and the risk of blood stream infection in extremely low birth weight infants, Cytokine, 53, 249, 10.1016/j.cyto.2010.11.003 · DOI
  17. Tolar, 2009, Immune regulatory cells in umbilical cord blood: T regulatory cells and mesenchymal stromal cells, Br J Haematol, 147, 200, 10.1111/j.1365-2141.2009.07781.x · DOI
  18. Risdon, 1995, Alloantigen priming induces a state of unresponsiveness in human umbilical cord blood T cells, Proc Natl Acad Sci U S A, 92, 2413, 10.1073/pnas.92.6.2413 · DOI
  19. Takahashi, 2009, Change of specific T cells in an emerging neonatal infectious disease induced by a bacterial superantigen, Microbiol Immunol, 53, 524, 10.1111/j.1348-0421.2009.00155.x · DOI
  20. Sautois, 1997, Comparative cytokine production by in vitro stimulated mononucleated cells from cord blood and adult blood, Exp Hematol, 25, 103
  21. Palmeira, 2012, IgG placental transfer in healthy and pathological pregnancies, Clin Dev Immunol, 2012, 985646, 10.1155/2012/985646 · DOI · Paper page
  22. Malek, 2003, Ex vivo human placenta models: transport of immunoglobulin G and its subclasses, Vaccine, 21, 3362, 10.1016/S0264-410X(03)00333-5 · DOI
  23. Zandvoort, 2002, The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens, Clin Exp Immunol, 130, 4, 10.1046/j.1365-2249.2002.01953.x · DOI
  24. Brandtzaeg, 2010, The mucosal immune system and its integration with the mammary glands, J Pediatr, 156, S8, 10.1016/j.jpeds.2009.11.014 · DOI · Paper page
  25. Hogasen, 2000, The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency, J Perinat Med, 28, 39, 10.1515/JPM.2000.006 · doi:10.1515/jpm.2000.006
  26. Suzuki-Nishimura, 1991, Binding of spin-labeled fatty acids and lysophospholipids to hydrophobic region of calmodulin, J Biochem, 110, 333, 10.1093/oxfordjournals.jbchem.a123581 · doi:10.1093/oxfordjournals.jbchem.a123581
  27. Imperi, 2011, Invasive neonatal GBS infections from an area-based surveillance study in Italy, Clin Microbiol Infect, 17, 1834, 10.1111/j.1469-0691.2011.03479.x · doi:10.1111/j.1469-0691.2011.03479.x
  28. Tomlinson, 2011, Rectovaginal Staphylococcus aureus colonization: is it a neonatal threat?, Am J Perinatol, 28, 673, 10.1055/s-0031-1276732 · doi:10.1055/s-0031-1276732
  29. Yancey, 1996, Risk factors for neonatal sepsis, Obstet Gynecol, 87, 188, 10.1016/0029-7844(95)00402-5 · doi:10.1016/0029-7844(95)00402-5
  30. Regan, 1996, Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group, Am J Obstet Gynecol, 174, 1354, 10.1016/S0002-9378(96)70684-1 · DOI · Paper page
  31. Schrag, 2000, Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis, N Engl J Med, 342, 15, 10.1056/NEJM200001063420103 · DOI · Paper page
  32. Tsai, 2012, Characteristics of early-onset neonatal sepsis caused by Escherichia coli, Taiwan J Obstet Gynecol, 51, 26, 10.1016/j.tjog.2012.01.006 · DOI
  33. Bizzarro, 2008, Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis, Pediatrics, 121, 689, 10.1542/peds.2007-2171 · DOI · Paper page
  34. Kaczmarek, 2012, Prevalence of genes encoding virulence factors among Escherichia coli with K1 antigen and non-K1 E. coli strains, J Med Microbiol, 61, 1360, 10.1099/jmm.0.044263-0 · doi:10.1099/jmm.0.044263-0
  35. Schrag, 2006, Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use, Pediatrics, 118, 570, 10.1542/peds.2005-3083 · DOI
  36. Al-Hasan, 2009, Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007, J Antimicrob Chemother, 64, 169, 10.1093/jac/dkp162 · DOI
  37. Puopolo, 2010, No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18 years, Pediatrics, 125, e1031, 10.1542/peds.2009-1573 · DOI
  38. Shetron-Rama, 2002, Intracellular induction of Listeria monocytogenes actA expression, Infect Immun, 70, 1087, 10.1128/IAI.70.3.1087-1096.2002 · DOI
  39. Moors, 1999, Expression of listeriolysin O and ActA by intracellular and extracellular Listeria monocytogenes, Infect Immun, 67, 131, 10.1128/IAI.67.1.131-139.1999 · DOI · Paper page
  40. Smith, 2009, Listeria monocytogenes: maternal-foetal infections in Denmark 1994-2005, Scand J Infect Dis, 41, 21, 10.1080/00365540802468094 · doi:10.1080/00365540802468094
  41. CDC, 1992, From the Centers for Disease Control. Foodborne listeriosis—United States, 1988-1990, JAMA, 267, 2446, 10.1001/jama.1992.03480180032011 · doi:10.1001/jama.1992.03480180032011
  42. Schlech, 2000, Foodborne listeriosis, Clin Infect Dis, 31, 770, 10.1086/314008 · DOI · Paper page
  43. Miyairi, 2004, Neonatal invasive group A streptococcal disease: case report and review of the literature, Pediatr Infect Dis J, 23, 161, 10.1097/01.inf.0000109887.40636.07 · doi:10.1097/01.inf.0000109887.40636.07
  44. Prommalikit, 2010, Invasive pneumococcal infection in neonates: 3 case reports, J Med Assoc Thai, 93, S46
  45. Malhotra, 2012, Streptococcus pneumoniae sepsis in the newborn, J Paediatr Child Health, 48, E79, 10.1111/j.1440-1754.2010.01929.x · doi:10.1111/j.1440-1754.2010.01929.x
  46. Gomez, 1999, Neonatal Streptococcus pneumoniae infection: case reports and review of the literature, Pediatr Infect Dis J, 18, 1014, 10.1097/00006454-199911000-00016 · DOI
  47. Appelbaum, 1980, Neonatal sepsis due to group G streptococci, Acta Paediatr Scand, 69, 559, 10.1111/j.1651-2227.1980.tb07133.x · doi:10.1111/j.1651-2227.1980.tb07133.x
  48. West, 1998, Speciation of presumptive viridans streptococci from early onset neonatal sepsis, J Med Microbiol, 47, 923, 10.1099/00222615-47-10-923 · DOI
  49. Dobson, 1990, Enterococcal sepsis in neonates: features by age at onset and occurrence of focal infection, Pediatrics, 85, 165, 10.1542/peds.85.2.165 · doi:10.1542/peds.85.2.165
  50. Ault, 1994, Vaginal flora as the source for neonatal early onset Haemophilus influenzae sepsis, Pediatr Infect Dis J, 13, 243, 10.1097/00006454-199403000-00021 · doi:10.1097/00006454-199403000-00021
  51. Hershckowitz, 2004, A cluster of early neonatal sepsis and pneumonia caused by nontypable Haemophilus influenzae, Pediatr Infect Dis J, 23, 1061, 10.1097/01.inf.0000143650.52692.42 · doi:10.1097/01.inf.0000143650.52692.42
  52. Takala, 1991, Neonatal Haemophilus influenzae infections, Arch Dis Child, 66, 437, 10.1136/adc.66.4_Spec_No.437 · doi:10.1136/adc.66.4_spec_no.437
  53. Didier, 2012, Late-onset neonatal infections: incidences and pathogens in the era of antenatal antibiotics, Eur J Pediatr, 171, 681, 10.1007/s00431-011-1639-7 · DOI
  54. Lim, 2012, Prevalence and pathogen distribution of neonatal sepsis among very-low-birth-weight infants, Pediatr Neonatol, 53, 228, 10.1016/j.pedneo.2012.06.003 · doi:10.1016/j.pedneo.2012.06.003
  55. Shane, 2012, Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants, Pediatrics, 129, e914, 10.1542/peds.2011-0966 · doi:10.1542/peds.2011-0966
  56. de Silva, 2002, The ica operon and biofilm production in coagulase-negative Staphylococci associated with carriage and disease in a neonatal intensive care unit, J Clin Microbiol, 40, 382, 10.1128/JCM.40.02.382-388.2002 · doi:10.1128/jcm.40.02.382-388.2002
  57. Drudy, 2006, Enterobacter sakazakii: an emerging pathogen in powdered infant formula, Clin Infect Dis, 42, 996, 10.1086/501019 · DOI
  58. Tresoldi, 2000, Enterobacter cloacae sepsis outbreak in a newborn unit caused by contaminated total parenteral nutrition solution, Am J Infect Control, 28, 258, 10.1067/mic.2000.105286 · DOI
  59. Cohen-Wolkowiez, 2009, Early and late onset sepsis in late preterm infants, Pediatr Infect Dis J, 28, 1052, 10.1097/INF.0b013e3181acf6bd · DOI · Paper page
  60. Bell, 2005, Neonatal sepsis in Jamaican neonates, Ann Trop Paediatr, 25, 293, 10.1179/146532805X72449 · DOI
  61. Leibovitz, 1997, Sepsis at a neonatal intensive care unit: a four-year retrospective study (1989-1992), Isr J Med Sci, 33, 734
  62. Townsend, 2008, Virulence studies of Enterobacter sakazakii isolates associated with a neonatal intensive care unit outbreak, BMC Microbiol, 8, 64, 10.1186/1471-2180-8-64 · doi:10.1186/1471-2180-8-64
  63. Etuwewe, 2009, Brain abscesses due to Citrobacter koseri in a pair of twins, Pediatr Infect Dis J, 28, 1035, 10.1097/INF.0b013e3181b6b064 · doi:10.1097/inf.0b013e3181b6b064
  64. Townsend, 2003, Citrobacter koseri brain abscess in the neonatal rat: survival and replication within human and rat macrophages, Infect Immun, 71, 5871, 10.1128/IAI.71.10.5871-5880.2003 · DOI
  65. Benjamin, 2006, Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months, Pediatrics, 117, 84, 10.1542/peds.2004-2292 · DOI · Paper page
  66. Neu, 2009, Epidemiology of candidemia at a children's hospital, 2002 to 2006, Pediatr Infect Dis J, 28, 806, 10.1097/INF.0b013e3181a0d78d · DOI
  67. Bliss, 2012, Candida virulence properties and adverse clinical outcomes in neonatal candidiasis, J Pediatr, 161, 441, 10.1016/j.jpeds.2012.02.051 · DOI
  68. Stoll, 2004, To tap or not to tap: high likelihood of meningitis without sepsis among very low birth weight infants, Pediatrics, 113, 1181, 10.1542/peds.113.5.1181 · DOI · Paper page
  69. Jawaheer, 1997, Blood culture volume and detection of coagulase negative staphylococcal septicaemia in neonates, Arch Dis Child Fetal Neonatal Ed, 76, F57, 10.1136/fn.76.1.F57 · doi:10.1136/fn.76.1.f57
  70. Neal, 1986, Volume of blood submitted for culture from neonates, J Clin Microbiol, 24, 353, 10.1128/JCM.24.3.353-356.1986 · DOI
  71. Visser, 1979, Urine culture in the evaluation of suspected neonatal sepsis, J Pediatr, 94, 635, 10.1016/S0022-3476(79)80040-2 · doi:10.1016/s0022-3476(79)80040-2
  72. Wiswell, 1995, No lumbar puncture in the evaluation for early neonatal sepsis: will meningitis be missed?, Pediatrics, 95, 803
  73. Lakeman, 1995, Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group, J Infect Dis, 171, 857, 10.1093/infdis/171.4.857 · DOI · Paper page
  74. Simko, 2002, Differences in laboratory findings for cerebrospinal fluid specimens obtained from patients with meningitis or encephalitis due to herpes simplex virus (HSV) documented by detection of HSV DNA, Clin Infect Dis, 35, 414, 10.1086/341979 · DOI · Paper page
  75. Christensen, 1985, Fatal early onset group B streptococcal sepsis with normal leukocyte counts, Pediatr Infect Dis, 4, 242, 10.1097/00006454-198505000-00006 · doi:10.1097/00006454-198505000-00006
  76. Hornik, 2012, Use of the complete blood cell count in early-onset neonatal sepsis, Pediatr Infect Dis J, 31, 799, 10.1097/INF.0b013e318256905c · DOI · Paper page
  77. Murphy, 2012, Use of leukocyte counts in evaluation of early-onset neonatal sepsis, Pediatr Infect Dis J, 31, 16, 10.1097/INF.0b013e31822ffc17 · doi:10.1097/inf.0b013e31822ffc17
  78. Tillett, 1930, Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus, J Exp Med, 52, 561, 10.1084/jem.52.4.561 · DOI · Paper page
  79. Hengst, 2003, The role of C-reactive protein in the evaluation and management of infants with suspected sepsis, Adv Neonatal Care, 3, 3, 10.1053/adnc.2003.50010 · DOI
  80. Philip, 2000, Use of C-reactive protein in minimizing antibiotic exposure: experience with infants initially admitted to a well-baby nursery, Pediatrics, 106, E4, 10.1542/peds.106.1.e4 · DOI
  81. Chiesa, 2001, Serial measurements of C-reactive protein and interleukin-6 in the immediate postnatal period: reference intervals and analysis of maternal and perinatal confounders, Clin Chem, 47, 1016, 10.1093/clinchem/47.6.1016 · DOI
  82. Forest, 1986, C-reactive protein as biochemical indicator of bacterial infection in neonates, Clin Biochem, 19, 192, 10.1016/S0009-9120(86)80023-6 · doi:10.1016/s0009-9120(86)80023-6
  83. Chiesa, 2011, C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period, Clin Chim Acta, 412, 1053, 10.1016/j.cca.2011.02.020 · DOI · Paper page
  84. Hofer, 2011, Non-infectious conditions and gestational age influence C-reactive protein values in newborns during the first 3 days of life, Clin Chem Lab Med, 49, 297, 10.1515/CCLM.2011.048 · DOI
  85. Auriti, 2012, Procalcitonin in detecting neonatal nosocomial sepsis, Arch Dis Child Fetal Neonatal Ed, 97, F368, 10.1136/fetalneonatal-2010-194100 · DOI
  86. Vouloumanou, 2011, Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis, Intensive Care Med, 37, 747, 10.1007/s00134-011-2174-8 · DOI
  87. Neth, 2000, Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition, Infect Immun, 68, 688, 10.1128/IAI.68.2.688-693.2000 · DOI · Paper page
  88. Ozkan, 2012, Serum mannose-binding lectin (MBL) gene polymorphism and low MBL levels are associated with neonatal sepsis and pneumonia, J Perinatol, 32, 210, 10.1038/jp.2011.79 · doi:10.1038/jp.2011.79
  89. Ng, 2003, Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections, Arch Dis Child Fetal Neonatal Ed, 88, F209, 10.1136/fn.88.3.F209 · DOI
  90. Resch, 2003, Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate, Acta Paediatr, 92, 243, 10.1111/j.1651-2227.2003.tb00534.x · doi:10.1111/j.1651-2227.2003.tb00534.x
  91. Genel, 2012, Evaluation of adhesion molecules CD64, CD11b and CD62L in neutrophils and monocytes of peripheral blood for early diagnosis of neonatal infection, World J Pediatr, 8, 72, 10.1007/s12519-011-0304-6 · doi:10.1007/s12519-011-0304-6
  92. Pammi, 2011, Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia, Cochrane Database Syst Rev, 10.1002/14651858.CD003956.pub2 · doi:10.1002/14651858.cd003956.pub2
  93. Ng, 2010, Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants, J Clin Invest, 120, 2989, 10.1172/JCI40196 · DOI · Paper page
  94. Daniels, 2011, Intrapartum tests for group B streptococcus: accuracy and acceptability of screening, BJOG, 118, 257, 10.1111/j.1471-0528.2010.02725.x · DOI
  95. Polin, 2012, Strategies for prevention of health care-associated infections in the NICU, Pediatrics, 129, e1085, 10.1542/peds.2012-0145 · DOI
  96. Kilbride, 2003, Implementation of evidence-based potentially better practices to decrease nosocomial infections, Pediatrics, 111, e519, 10.1542/peds.111.SE1.e519 · DOI
  97. Bloom, 2003, Reducing acquired infections in the NICU: observing and implementing meaningful differences in process between high and low acquired infection rate centers, J Perinatol, 23, 489, 10.1038/sj.jp.7210981 · doi:10.1038/sj.jp.7210981
  98. Andersen, 2005, Prospective evaluation of a multi-factorial prevention strategy on the impact of nosocomial infection in very-low-birthweight infants, J Hosp Infect, 61, 162, 10.1016/j.jhin.2005.02.002 · doi:10.1016/j.jhin.2005.02.002
  99. Shah, 2005, Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters, Cochrane Database Syst Rev, 10.1002/14651858.CD002772.pub2 · doi:10.1002/14651858.cd002772.pub2
  100. Birch, 2010, A randomised, controlled trial of heparin in total parenteral nutrition to prevent sepsis associated with neonatal long lines: the Heparin in Long Line Total Parenteral Nutrition (HILLTOP) trial, Arch Dis Child Fetal Neonatal Ed, 95, F252, 10.1136/adc.2009.167403 · doi:10.1136/adc.2009.167403
  101. Fanaroff, 1994, A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network, N Engl J Med, 330, 1107, 10.1056/NEJM199404213301602 · DOI · Paper page
  102. Ohlsson, 2010, Intravenous immunoglobulin for suspected or subsequently proven infection in neonates, Cochrane Database Syst Rev, 10.1002/14651858.CD001239.pub3 · DOI
  103. Brocklehurst, 2011, Treatment of neonatal sepsis with intravenous immune globulin, N Engl J Med, 365, 1201, 10.1056/NEJMoa1100441 · DOI · Paper page
  104. Vernachio, 2003, Anti-clumping factor A immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis, Antimicrob Agents Chemother, 47, 3400, 10.1128/AAC.47.11.3400-3406.2003 · DOI
  105. Weisman, 2011, A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis, Pediatrics, 128, 271, 10.1542/peds.2010-3081 · DOI
  106. Benjamin, 2006, A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin, J Perinatol, 26, 290, 10.1038/sj.jp.7211496 · DOI
  107. Bloom, 2005, Multicenter study to assess safety and efficacy of INH-A21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants, Pediatr Infect Dis J, 24, 858, 10.1097/01.inf.0000180504.66437.1f · DOI
  108. Shah, 2009, Antistaphylococcal immunoglobulins to prevent staphylococcal infection in very low birth weight infants, Cochrane Database Syst Rev, 10.1002/14651858.CD006449.pub2 · doi:10.1002/14651858.cd006449.pub2
  109. Carr, 2009, Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial, Lancet, 373, 226, 10.1016/S0140-6736(09)60071-4 · DOI
  110. Poindexter, 2003, Effect of parenteral glutamine supplementation on plasma amino acid concentrations in extremely low-birth-weight infants, Am J Clin Nutr, 77, 737, 10.1093/ajcn/77.3.737 · doi:10.1093/ajcn/77.3.737
  111. Tubman, 2008, Glutamine supplementation to prevent morbidity and mortality in preterm infants, Cochrane Database Syst Rev, 10.1002/14651858.CD001457.pub3 · DOI
  112. Alfaleh, 2011, Probiotics for prevention of necrotizing enterocolitis in preterm infants, Cochrane Database Syst Rev, 10.1002/14651858.CD005496.pub3 · DOI · Paper page
  113. Bonsante, 2012, Routine probiotic use in very preterm infants: retrospective comparison of two cohorts, Am J Perinatol
  114. Deshpande, 2010, Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates, Pediatrics, 125, 921, 10.1542/peds.2009-1301 · DOI · Paper page
  115. Manzoni, 2009, Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial, JAMA, 302, 1421, 10.1001/jama.2009.1403 · DOI · Paper page
  116. Manzoni, 2007, A multicenter, randomized trial of prophylactic fluconazole in preterm neonates, N Engl J Med, 356, 2483, 10.1056/NEJMoa065733 · DOI · Paper page
  117. Kaufman, 2011, Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age, J Pediatr, 158, 759, 10.1016/j.jpeds.2010.11.002 · DOI
  118. Kicklighter, 2001, Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant, Pediatrics, 107, 293, 10.1542/peds.107.2.293 · DOI · Paper page
  119. Healy, 2008, Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species, Pediatrics, 121, 703, 10.1542/peds.2007-1130 · DOI
  120. Cotten, 2009, Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants, Pediatrics, 123, 58, 10.1542/peds.2007-3423 · DOI · Paper page
  121. Kuppala, 2011, Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants, J Pediatr, 159, 720, 10.1016/j.jpeds.2011.05.033 · DOI · Paper page
  122. Arslan, 2010, Serratia marcescens sepsis outbreak in a neonatal intensive care unit, Pediatr Int, 52, 208, 10.1111/j.1442-200X.2009.02934.x · doi:10.1111/j.1442-200x.2009.02934.x
  123. Dashti, 2010, Transmission of a Klebsiella pneumoniae clone harbouring genes for CTX-M-15-like and SHV-112 enzymes in a neonatal intensive care unit of a Kuwaiti hospital, J Med Microbiol, 59, 687, 10.1099/jmm.0.019208-0 · doi:10.1099/jmm.0.019208-0
  124. Golan, 2005, Transmission of vancomycin-resistant enterococcus in a neonatal intensive care unit, Pediatr Infect Dis J, 24, 566, 10.1097/01.inf.0000164762.03930.0a · doi:10.1097/01.inf.0000164762.03930.0a
  125. Linkin, 2004, Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae in a neonatal intensive care unit, Infect Control Hosp Epidemiol, 25, 781, 10.1086/502477 · doi:10.1086/502477
  126. Maraki, 2009, Chryseobacterium meningosepticum colonization outbreak in a neonatal intensive care unit, Eur J Clin Microbiol Infect Dis, 28, 1415, 10.1007/s10096-009-0797-2 · doi:10.1007/s10096-009-0797-2
  127. Touati, 2009, Outbreak of Acinetobacter baumannii in a neonatal intensive care unit: antimicrobial susceptibility and genotyping analysis, Ann Epidemiol, 19, 372, 10.1016/j.annepidem.2009.03.010 · doi:10.1016/j.annepidem.2009.03.010
  128. Patel, 2009, Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial Resistance, Pediatr Infect Dis J, 28, 1047, 10.1097/INF.0b013e3181b12484 · DOI
  129. Tamma, 2011, Antimicrobial stewardship, Infect Dis Clin North Am, 25, 245, 10.1016/j.idc.2010.11.011 · DOI · Paper page
  130. Patel, 2012, Development of an antimicrobial stewardship intervention using a model of actionable feedback, Interdiscip Perspect Infect Dis, 2012, 150367, 10.1155/2012/150367 · DOI
  131. Chen, 2011, Echinocandin antifungal drugs in fungal infections: a comparison, Drugs, 71, 11, 10.2165/11585270-000000000-00000 · DOI · Paper page
  132. Smith, 2009, Pharmacokinetics of an elevated dosage of micafungin in premature neonates, Pediatr Infect Dis J, 28, 412, 10.1097/INF.0b013e3181910e2d · DOI · Paper page
  133. Heresi, 2006, The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants, Pediatr Infect Dis J, 25, 1110, 10.1097/01.inf.0000245103.07614.e1 · DOI · Paper page
  134. Benjamin, 2010, Safety and pharmacokinetics of repeat-dose micafungin in young infants, Clin Pharmacol Ther, 87, 93, 10.1038/clpt.2009.200 · DOI

Cited by

See all 459

Metadata

Authors
Camacho-Gonzalez, A., Spearman, P. W., & Stoll, B. J.
Venue
Pediatric Clinics of North America
Publisher
Elsevier BV
Published
2013-04
Volume
60
Issue
2
Pages
367-389
ISSN
0031-3955 (ISSN-L)
DOI
10.1016/j.pcl.2012.12.003
OpenAlex
W20272483
Cited by
459
References
6
FWCI
27.73
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neonatal Infectious Diseases. https://app.cochat.ai/papers/10.1016/j.pcl.2012.12.003
The paper
Camacho-Gonzalez, A., Spearman, P. W., & Stoll, B. J. (2013). Neonatal Infectious Diseases. Pediatric Clinics of North America. https://doi.org/10.1016/j.pcl.2012.12.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.